Management of Atopic Dermatitis

Provides proven strategies for treating atopic dermatitis Describes the special considerations for atopic dermatitis in skin of color patients Helps providers create a treatment plan for their atopic patients

Autorentext

Lindsay C. Strowd is an Associate Professor and Interim Chair of Dermatology at the Wake Forest University School of Medicine.

Steven R. Feldman is a Professor of Dermatology and Public Health Sciences at the Wake Forest University School of Medicine.

**Katie K. Lovell **is a research fellow in the Department of Dermatology at the Wake Forest University School of Medicine and M.D. Candidate at East Carolina University Brody School of Medicine.

Inhalt
Introduction.- Atopic Dermatitis: Disease Background and Risk Factors.- Atopic Dermatitis: Pathophysiology.- Clinical Presentation of Atopic Dermatitis.- Special Considerations for Atopic Dermatitis in Skin of Color Patients.- Atopic Dermatitis Disease Complications.- The Psychosocial Impact of Atopic Dermatitis.- Stressors in Atopic Dermatitis.- The Economics Burden of Atopic Dermatitis.- Defining and Measuring the Scope of Atopic Dermatitis.- Topical Prescription Management (including new topical JAK).- Oral Prescription Management (including new oral JAKs).-Introduction.- Atopic Dermatitis: Disease Background and Risk Factors.- Atopic Dermatitis: Pathophysiology.- Clinical Presentation of Atopic Dermatitis.- Special Considerations for Atopic Dermatitis in Skin of Color Patients.- Atopic Dermatitis Disease Complications.- The Psychosocial Impact of Atopic Dermatitis.- Stressors in Atopic Dermatitis.- The Economics Burden of Atopic Dermatitis.- Defining and Measuring the Scope of Atopic Dermatitis.- Topical Prescription Management (including new topical JAK).- Oral Prescription Management (including new oral JAKs).- Systemic Biologic Management (dupilumab and tralokinumab).- Non-Prescription Treatment Options.- Adherence in Atopic Dermatitis.- Atopic Dermatitis: Managing the Itch.- Atopic Dermatitis Disease Education.- Guidelines from American Academy of Dermatology.- The Future of Atopic Dermatitis Treatment (to be updatedsome drugs discussed in this chapter are now FDA approved).